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munity, DNA damage and repair, cell signaling and cell cycle. Unlike RING-type neddylation ligases, HECT-type
neddylation ligase remains less deﬁned. Here, we show that Itch is a novel HECT-type neddylation E3 ligase
andwe identify JunB as a substrate of Nedd8modiﬁcation by Itch. JunB neddylation attenuates its transcriptional
activity. In addition, JunB neddylation mediated by Itch promotes its ubiquitination-dependent degradation.
Therefore, these ﬁndings deﬁne a new HECT-type neddylation ligase and its neddylation substrate.
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As an important ubiquitin-likemodiﬁcation, neddylationmachinery
is mainly consisted of a activating enzyme E1 (UBA3/APPBP1 heterodi-
mer), conjugating enzyme E2s (Ube2M/Ubc12 or Ube2F) and E3 ligases,
which then ensure speciﬁc conjugation of ubiquitin-like Nedd8 (Neural
precursor cell-expressed developmentally down-regulated 8) to the
substrates [1–5]. Genetic studies have demonstrated that neddylation
is essential in mammals [6], fruit-ﬂies [7], nematodes [8], plants [9]
and ﬁssion yeast [10]. Neddylation was required for the ubiquitin ligase
activity of cullin-RING ligases (CRLs) that controlled many key cellular
pathways dysregulated in many cancers [11,12]. MLN4924, a potent in-
hibitor of Nedd8-activating enzyme (NAE), was being applied to treat
some cancers like haematological and solid tumour malignancies in
the ﬁrst clinical trial [13,14].Proteomics, Beijing Proteome
ollaborative Innovation Center
f Proteomics, Beijing Proteome
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@nic.bmi.ac.cn (L. Zhang).
. This is an open access article underIn recent years, several neddylation E3 ligases have been reported,
including the best-characterized and fully validated cullin neddylation
ligase Rbx1 and the non-cullin Nedd8 ligases MDM2, c-Cbl, IAPs and
RNF111 [4,5,15–18]. Our previous study has reported that SMURF1
(Smad ubiquitination regulatory factor 1), as well as its budding yeast
orthologue Rsp5, can catalyze the auto-neddylation and the auto-
neddylation enhanced the ubiquitin ligase activity of Smurf1 or Rsp5
[19]. This is the ﬁrst time to show the activating role of neddylation in
HECT-type ubiquitin ligase regulation. However, whether HECT-type
ubiquitin ligase(s) can catalyze the neddylation of protein substrate re-
mains to be deﬁned. In human genome, the 28HECT E3 ubiquitin ligases
have been identiﬁed and grouped into three families, in which Nedd4
family was composed of 9 members including Smurf1 [20]. The aim of
this study is to reveal which member(s) of the whole Nedd4 family
can be auto-neddylated and to identify the neddylation substrate as
well as the function.
In this study, we demonstrate that among the nine members of
Nedd4 family, ﬁve members, i.e. Smurf1, Smurf2, Itch, NEDL1 and
NEDL2 can catalyze the auto-neddylation. Itch is unique since the
neddylated Itch migrated as a single band rather than smear bands.
Our in-depth investigations showed that Itch interacted with Ubc12 in
a typical E3-E2 binding pattern and Itch acted as a neddylation E3 to
promote the neddylation of JunB. This modiﬁcation inhibits thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ubiquitination-dependent degradation of JunB. Therefore, these ﬁnd-
ings for the ﬁrst time identiﬁed a novel HECT-type neddylation ligase
and its neddylation substrate.
2. Materials and methods
2.1. Reagents and antibodies
All antibodies were purchased as follows: Antibodies against Itch
(ab31097, Abcam), anti-JunB (#3753, CST), anti-Ubc12 (ab56383,
Abcam), anti-Nedd8 (ALX-210-194-R200, Alexis Biochemicals), anti-
Uba3 (PAB1774, Abnova), anti-Myc, anti-GST, anti-His, anti-HA, anti-
GAPDH (MBL), anti-Flag (Sigma-Aldrich) and mouse/rabbit IgG (Santa
Cruz).
2.2. Preparation and transfection of plasmids or siRNA interference
Flag-tagged human Itch, Myc-tagged Itch and GST-Itch or truncates
were constructed with the template of HA-Itch provided by ZF Jiang
[21]. AP-1 reporter plasmids were used according to the previous
study [22]. Site-speciﬁc mutations of JunB were performed using PCR-
based mutagenesis. Moreover, Nedd8, Ubc12 or its truncates, NEDP1
and NEDP1-C163A plasmids were as described in the previous study
[19]. All mutagenic constructs generated were conﬁrmed by sequence
analysis. HEK293T and HCT116 cells were transfected with TurboFect
(R0531, Thermo Scientiﬁc). siRNA against Uba3 and Ubc12 were de-
signed according to the previous work [19].
For lentiviral transduction, Ubc12 shRNA and control shRNA plasmids
in the pGreenpuro backbone were designed and synthesized. For Ubc12
shRNA, the forward oligo used was ′5-GATCCCCAGTCCTTACGATAAACT
CTTCCTGTCAGAAGTTTATCGTAAGGACTGGTTTTTG-3′ and the reverse
oligo was ′5-AATTCAAAAACCAGTCCTTACGATAAACTTC TGACAGGAAGA
GTTTATCGTAAGGACTGGG-3′. For control shRNA, the forward oligo used
was ′5-GATCCTTCTCCGAACGTGTCACGTCTTCCTGTCAGAACGTGACACGT
TCGGAGAATTTTTG-3′ and the reverse oligo was ′5-AATTCAAAAA TTCT
CCGAACGTG TCACGTTCTGACAGGAAGACGTGACACGTTCGGAGAA G-3′.
Lentiviruses package was referred to our lab's previous studies [23].
2.3. Co-immunoprecipitation assay
Cells were harvested at 48 h post-transfection and lysed in HEPES
lysis buffer (20 mM HEPES, pH 7.2, 50 mM NaCl, 0.5% Triton X-100,
1 mMNaF and 1 mMDTT) supplemented with protease inhibitor cock-
tail (Roche). Immunoprecipitationswere performed using the indicated
primary antibody for 3–4 h and protein A/G-agarose beads (Santa Cruz)
overnight at 4 °C. The resulting immunoprecipitates were washed at
least three times in HEPES lysis buffer. Lysates and immunoprecipitates
were examined using the indicated primary antibodies followed by de-
tectionwith the related secondary antibody and the SuperSignal chemi-
luminescence kit (Thermo).
2.4. GST pull-down
Bacteria-expressed GST, GST-Ubc12, GST-Ubc12 truncate or mutant,
GST-Itch or truncates proteins were immobilized on Glutathione-Se-
pharose 4B beads (Amersham Biosciences) and washed, and then
beads were incubated with His-Itch or His-Ubc12 for 8 h at 4 °C under
rotation. Beads were washed with GST-binding buffer (100 mM NaCl,
50 mM NaF, 2 mM EDTA, 1% NP-40 and protease inhibitor mixture)
and proteins were eluted, followed by immunoblotting.
2.5. His pull-down and neddylation assay by Ni-NTA columns
Cells were collected in PBS buffer containing 5 mM NEM. Cells were
resuspended in binding buffer (6 M guanidine HCl, 0.1 M Na2HPO4,0.1 M NaH2PO4, 0.01 M Tris (pH 8.0), 10 mM β-mercaptoethanol,
5 mM NEM, 5 mM imidazole) and incubated with Ni-NTA agarose
(Qiagen) at 4 °C for 12 h. Ni-NTA-mediated pull-down assays were per-
formed as described [24]. Immunoblotting was performed using anti-
Flag and anti-HA antibodies.
2.6. In vivo neddylation assay
For in vivo neddylation assays, cells were collected, and they were
lysed in modiﬁed RIPA lysis buffer (10 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 5 mM EDTA, 1% (v/v) NP-40, 1% sodium deoxycholate, 0.1% SDS,
1 mMprotease inhibitors). The lysate was incubated with the indicated
antibody for 3 h at 4 °C. Protein A/G-plus Agarose (Santa Cruz) was
added, and the lysatewas rotated gently for 8 h at 4 °C. The immunopre-
cipitates werewashed at least three timeswith RIPA buffer. Precipitated
proteins were detected by immunoblotting.
2.7. In vitro neddylation assays
In vitro neddylation was performed with recombinant puriﬁed en-
zymes. His-Itch and Myc-JunB were expressed in Escherichia coli BL21
(DE3) or HEK293T, respectively. 10 ng His-Itch or certain Myc-JunB
was incubated with 2 mg Nedd8, 10 ng E1 (APPBP1-UBA3) and
200 ng E2 (Ubc12) in a total reaction volume of 20 μL (40 mM Tris–
HCl, pH 7.4, 5 mMMgCl2, 2 mM ATP and 2 mM DTT). Samples were in-
cubated at 30 °C for 1 h, and reactions were terminated with 2 × SDS-
PAGE loading buffer (20 mM Tris–HCl, pH 6.8, 100 mM DTT, 2% SDS,
20% glycerol and 0.016% Bromophenol blue) before western blotting.
If needed, the neddylation reaction sample was ﬁrst puriﬁed with
Ni2+-NTA Superﬂow Cartridges (QIAGEN).
2.8. Real-time PCR
For mRNA analysis, total RNA was isolated by Trizol, and was con-
verted to cDNA using Rever TraAceq PCR RT Kit (TOYOBO). Quantitative
PCR was performed using the Bio-Rad IQ5 System (Bio-Rad). PCR reac-
tionswere carried out in 20 μL reactions usingKAPA SYBR FAST qPCRKit
Master Mix (2X) Universal (KAPA BIOSYSTEMS) and 0.2 mM speciﬁc
primers. Primer sequences for speciﬁc genes were described as follows,
Actin-up: GACTGACTACCTCATGAAGAT, Actin-down: ACTTCATGATGGA
GTTGAAGG; Cyclin D1-up: AGCTGCTGCAAATGGAGC, Cyclin D1-down:
GGGTCACACTTGATCAC TCTGG.
2.9. Reporter gene assay
293T cells were seeded into a 24-well plate and transfected with
10 ng pRL-CMV (Renilla control luciferase, Promega) and 0.1 mg pAP-
1-luc (ﬁreﬂy luciferase, Stratagene) reporter gene plasmids and various
constructs related to the study. After 24 h, luciferase activity was mea-
sured and normalized to the co-transfected Renilla luciferase activity
(mean ± s.d., n = 3). After transfection for 48 h, cells were lysed in a
passive lysis buffer (Promega). Luciferase activity was measured with
the Dual Luciferase Assay System (Promega) in accordance with the
manufacturer's protocol.
2.10. Isolation of umbilical cord blood mesenchymal stem cells (UC-MSCs)
In accordance with the Ethics Committee at the Beijing Institute of
Radiation, umbilical cord samples from full-term pregnancies of normal
healthy donors were obtained from 301 hospitals of the Chinese
People's Liberation Army. Under sterile conditions, UCs were rinsed
three times with phosphate-buffered saline (PBS) to remove contami-
nating blood. Samples were cut into 2-cm segments, and UC arteries,
veins and amnion were removed. The gelatinous tissue was then ex-
cised and minced into 0.5- to 1-mm3 pieces. The minced pieces were
placed in a plastic ﬂask, and, after 3 h, Dulbecco's modiﬁed Eagle's
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100 U/mL of Pen/Strep was added. The MSCs were cultured at 37 °C in
a humidiﬁed atmosphere containing 5% CO2 with medium changes
every 3 days. At approximately 80% conﬂuency, the cells were passaged
with 0.05% trypsin and seeded in a new culture ﬂack. In addition, UC-
MSCs sorting was referred to the previous study [25].
2.11. Statistical analysis
The Student's paired t testwas used to check for differences between
two groups. The results were expressed as the mean ± SD. All experi-
ments have been done at least three times independently. Values
P b 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Nedd8 is attached to Itch through auto-neddylation
A previous study have showed that HECT-type ligase Smurf1 could
be auto-neddylated [19]. We wondered whether other HECT-type li-
gases of Nedd4 family could be conjugated with Nedd8. The results
showed that Smurf1, Smurf2, NEDL1, NEDL2 and Itch E3 ligases could
be signiﬁcantly conjugated with Nedd8 (Fig. 1). Interestingly, only Itch
was conjugated with mono-Nedd8 in these ﬁve candidates (Fig. 1).
The E3 protein ubiquitin ligase Itch (also known as atrophin-1
interacting protein 4, AIP4), consisting of an N-terminal protein-kinase
C-related C2 domain, followed by four protein-interacting WW do-
mains, and a C-terminal HECT E3 ligase domain,was crucial formanybi-
ological processes including T cell activation and differentiation, cancer
and bone homeostasis [26,27]. Itch−/−mice also signiﬁcantly increased
bone volume, osteoblast numbers and bone formation rate compared
with the wild-type mice besides immunological disorders [28].
We veriﬁed the possible relationship between Itch and protein
neddylation. Firstly, pull-down assay showed that Itch was covalently
attached with mono-Nedd8. Nedd8 wild type but not Nedd8-ΔGGFig. 1. Screen the candidates of Nedd4 family that could be self auto-neddylated. The plasmids e
cells in the indicated combinations. After 48 h transfection, the cells were collected and analyz(deletion of the C-terminus glycines) was attached to Itch (Fig. 2A and
B). Mono-neddylation of Itch was not detected after treatment with
MLN4924, the neddylation E1 inhibitor (Fig. 2C) and in vitro
neddylation assay showed that mono-neddylation of Itch was detected
(Fig. 2D). Thus, Itwas indicated that Itchwasmono-neddylated in exog-
enous over-expression and in vitro conditions. The fact that Smurf1 was
effectively self-neddylated prompted us to hypothesize that Itch might
function as a Nedd8 ligase to catalyze its own neddylation. If this is
true, which cysteine functions as the catalytic active site? We ﬁrstly in-
vestigatedwhether its ubiquitin ligase catalytic activity center C830was
the Nedd8 ligase catalytic activity center. Neddylation assays revealed
that Itch C830A could not be attached with mono-Nedd8 both in vitro
and in vivo (Fig. 2D and E), indicating that C830 was also the Nedd8 li-
gase catalytic activity center of Itch and Itch self neddylationwas depen-
dent on C830 (Fig. 2D and E). To further verify that this conjugationwas
neddylation, we found that the deneddylase NEDP1 WT removed this
conjugation but the NEDP1 catalytic-inactive C163A mutant did not,
suggesting that this conjugation was truly neddylation (Fig. 2F). Immu-
noprecipitation of the HCT116 cell lysates with anti-Itch-speciﬁc anti-
body showed that endogenous Itch neddylation was detectable (Fig.
2G), indicating Itch was neddylated in vivo. We isolated and identiﬁed
a human mesenchymal stem cells–umbilical cord blood mesenchymal
stem cells (UC-MSCs), which harbored the potential to differentiate
into osteoblast lineage. The deletion of Ubc12 led to the decrease in
Itch neddylation in UC-MSCs (Fig. 2H). Collectively, these results dem-
onstrated that Itch catalyzed its own mono-neddylation in vivo and in
vitro.
3.2. Itch associates with Ubc12
Given that Itch is a typical E3 neddylation ligase, we next tested
whether Itch could bind to the Nedd8 E2, Ubc12 (also known as
UBE2M). In vitro binding assays revealed that Itch could bind to Ubc12
(Fig. 3A) and the binding was unaffected by C830A mutation (Fig. 3A).
The H88 and D89 residues and amino acids 1–26 in the N-terminalncodingMyc-Nedd8 and themembers of Nedd4 family were co-transfected into HEK293T
ed by Co-IP.
Fig. 2.Mono-Nedd8 is attached to itch through auto-neddylation. (A, B) Itch was mono-neddylated in exogenous over-expression conditions. HEK293T cells were transfected with the
indicated plasmid combinations. The cells were collected and Ni-NTA-mediated pull-down assay was performed (A). Co-immunoprecipitation assay (Co-IP) was performed under
denaturing conditions (B). (C) Itch neddylation was inhibited by MLN4924. HEK293T cells were transfected as indicated. Cells were treated with 10 μM MLN4924 for 8 h before
collection. Flag-Itch was immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Nedd8 antibody. (D) Covalent neddylation of Itch in vitro. Puriﬁed His-Itch WT or
C830A proteins were incubated with Nedd8 and Nedd8-E1/E2. Reactions were performed as described in the Materials and methods section. Samples were analyzed by western
blotting with anti-His antibody. (E) The Neddylation enzymatic activity site of Itch was determined by Co-IP in HEK293T transfected with the indicated constructs. (F) Deneddylation
enzyme NEDP1 abolished Itch neddylation in HEK293T. After Cells were transfected with the indicated constructs for 48 h, Co-IP assays were performed. (G) Endogenous Itch
neddylation assay was performed in HCT116. Co-IP was performed with anti-Itch antibody. (H) The effect of Deleting Ubc12 on Endogenous Itch neddylation in primary cell human
UC-MSCs. Co-IP was performed with anti-Itch antibody.
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Strikingly, Itch could no longer bind toUbc12 if theUbc12ΔN26mutant
was tested for interaction (Fig. 3B), and Itch showed reduced binding to
Ubc12 H88A-D89A (both the 88th histidine and 89th aspartic acidmutated to alanine) (Fig. 3B). Thus, the Ubc12 sites for binding to Itch
appear to largely overlapwith that for the E1. In addition, deletion anal-
ysis indicated that the small subdomain of Itch HECT N-lobe mediated
the interaction with Ubc12 (Fig. 3C, D). This domain also mediates the
Fig. 3. Itch interacts with Ubc12. (A) GST pull-down assay of ItchWT or C830Awith Ubc12 in vitro. Both input andpull-down sampleswere subjected to immunoblottingwith anti-His and
anti-GST antibodies. (B)Mapping the regions ofUbc12 required for Itch binding. His-Itch and the indicatedmutant forms (ΔN26 andH88A-D89A) of GST-Ubc12were used in theGST pull-
down assay. (C) Itch truncates are constructed as the schematic diagram showed. The region of truncates as follows: C2 (1–143 aa),WW (283–475 aa), HECT (503–862 aa), N-Lobe (507–
742 aa), N-Lobe-L (507–673 aa), N-Lobe-S (674–742 aa), C-Lobe (743–862 aa). (D)Mapping theUbc12-binding region of Itch. GST pull-downassaywasperformed as indicated in vitro and
immunoblotted with anti-GST and anti-His antibody.
1190 H. Li et al. / Cellular Signalling 28 (2016) 1186–1195interaction with the ubiquitin E2 [20]. Thus, These results suggested
that Itch might function as a Nedd8 ligase.
3.3. Nedd8 is attached to JunB by Itch
To deﬁne a novel Nedd8 ligase, an important characteristic is to
identify its neddylation substrate. Considering that many neddylation
substrates were the ubiquitination substrates [17,18,31,32], we ﬁrstly
analyzed two well-studied ubiquitination substates of Itch: JunB and
c-Jun. Pull-down assay showed that Itch speciﬁcally promoted Nedd8Fig. 4. Itch could catalyze JunB neddylation. (A) The neddylation substrate of Itch was determin
constructs. After 48 h transfection, the cells were collected and analyzed by Ni-NTA-mediated p
Itch-C830A inHEK293T. (C) Itch-mediated JunB neddylationwas inhibited byMLN4924 inHEK
down assay was performed. (D) JunB neddylation was signiﬁcantly attenuated by depletio
transfected into HCT116 for 36 h, pull-down assay was performed. (E) Endogenous JunB ne
immunoblotted with anti-Nedd8 antibody. (F) Covalent neddylation of JunB in vitro. Puriﬁed
E2. Reactions were performed as described in the Materials and methods section. Samples w
NEDP1 abolished Itch-mediated JunB neddylation in HEK293T. After Cells were transfected
MLN4924 treatment and Deleting Ubc12 on Endogenous JunB neddylation in primary humanconjugation of JunB but not c-Jun (Fig. 4A). Itch C830A mutant did not
induce JunB neddylation (Fig. 4B). MLN4924 treatment inhibited Itch-
mediated JunB neddylation (Fig. 4C). Knockdown of Uba3 (E1) or
Ubc12 (E2) abolished Itch-mediated JunB neddylation (Fig. 4D), and
neddylation of JunB could be also detected at the endogenous level in
HCT116 (Fig. 4E). In vitroneddylation assay showed that Nedd8was sig-
niﬁcantly conjugated to JunB by Itch (Fig. 4F). Moreover, NEDP1WT re-
versed the Itch-mediated JunB neddylation but the NEDP1 C163A
mutant did not (Fig. 4G). In addition, MLN4924 treatment or deletion
of Ubc12 decreased JunB neddylation in primary cell human UC-MSCsed by the Ni-NTA-mediated pull-down assay in HEK293T transformed with the indicated
ull-down assay. (B) Ni-NTA-mediated pull-down assay of the JunB neddylation by Itch or
293T. After 36 h transfection,MLN4924was added into the culture up to 10 μMbefore pull-
n of Uba3 (one subunit of NAE) or Ubc12. After the indicated plasmids or siRNAs were
ddylation was analyzed in HCT116. Co-IP was performed with anti-JunB antibody and
Myc-JunB was incubated with puriﬁed His-Itch or His-Itch-C830A, Nedd8 and Nedd8-E1/
ere analyzed by western blotting with anti-Nedd8 antibody. (G) Deneddylation enzyme
with the indicated constructs for 48 h, Co-IP assay was performed. (H, I) The effect of
UC-MSCs. Co-IP was performed with anti-Nedd8 or anti-JunB antibody.
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Fig. 5. Identiﬁcation of the neddylation sites of JunB. (A) The domains and all lysine
residuals of JunB were marked in the schematic diagram. (B) Neddylation assays of the
domain of JunB. Flag-JunB, Flag-JunB-N-8KR, Flag-JunB-C-11KR and Flag-JunB-19KR
were transfected into HEK293T as indicated. Ni-NTA-mediated pull-down assays were
performed after 48 h transfection.
1192 H. Li et al. / Cellular Signalling 28 (2016) 1186–1195(Fig. 4H, I). Collectively, these results indicated that Itch could catalyze
the neddylation of JunB.
We next attempted to identify the neddylation sites of JunB. Scan-
ning of JunB sequence showed that it contains a total of 19 lysines, in-
cluding 8 lysines in the N terminal transcription activation domain
and 11 lysines in the C terminal DNA binding domain. We mutated
these lysine residues to arginine to generate three mutants, 19KR, N-
8KR and C-11KR (Fig. 5A). The results conﬁrmed that JunB 19KRmutant
could not be neddylated while N-8KR was less neddylated and C-11KR
was equally neddylated with JunB WT (Fig. 5B). The results suggested
that JunB neddylation sites mainly located in the N terminal transcrip-
tion activation domain.
3.4. Itch-mediated JunB neddylation attenuates its transcriptional activity
Considering that neddylation sites weremainly located in the N-ter-
minal domain of JunB, we investigated how neddylation affected the
transcriptional factor activity of JunB. JunB belonged to the AP-1 tran-
scriptional factor family. AP-1 luciferase reporter assay was used to as-
sess the effect of neddylation on the transcriptional activity of JunB.
Nedd8 but not ΔGG mutant could inhibit the JunB activity and co-ex-
pression of Itch with Nedd8 resulted in a more signiﬁcant effect (Fig.
6A and B). In contrast, MLN4924 treatment or NEDP1 expression
could increase the JunB activity (Fig. 6C and D). cyclinD1was the impor-
tant targets of JunB, in which JunB inhibited cyclinD1 transcription [33].
In HCT116 cell lines, MLN4924 treatment could markedly inhibit
cyclinD1 mRNA (Fig. 6E). Therefore, Itch-mediated JunB neddylation
inhibited the transcriptional factor activity of JunB.
3.5. Neddylation promotes the degradation of JunB
Next, we investigated whether Itch-mediated neddylation could af-
fect JunB stability and ubiquitination. In consistent with the fact that
JunB was the substrate of Itch ubiquitination ligase [34], co-expression
of JunB with Itch markedly decreased JunB levels (Fig. 7A). Moreover,
when co-express JunB with Itch and Nedd8, JunB level was less. It was
indicated that Itch self neddylation augments the ubiquitin ligase activ-
ity of Itch and further promotes the degradation of JunB. This effect of
Itch neddylation shared with that of Smurf1 in the previous study
[19]. JunB ubiquitination was promoted by Itch-induced neddylation,
whereas this effect did not happen by Itch C830A mutant(Fig. 7B). It
was indicated that Itch neddylation enhanced its ubiquitination activity
and facilitated the degradation of JunB.
4. Discussion
Our recent study has reported that human Smurf1 and the Nedd4
family orthologue Rsp5 in yeast can catalyze the auto-neddylation and
represents a novel activation pattern of HECT-type ubiquitin ligase
[19]. However, the identiﬁcation of HECT-type Nedd8 ligase still re-
mains unclear, in particular lack of the identiﬁcation of a neddylation
substrate. This study provides this missing piece in the ﬁeld. We clearly
demonstrate that Itch, anothermember of Nedd4/Smurf1 family, repre-
sents a novel HECT-type Nedd8 ligase and can catalyze the neddylation
of the transcriptional factor JunB. Itch could interact with Ubc12, and
catalyze the mono-neddylation of itself and the poly-neddylation of
JunB. The enzymatic center C830 of Itch Nedd8 ligase shared with its
ubiquitin enzymatic center. The neddylation of JunB by Itch facilitated
its degradation and attenuated the transcriptional activity.
In the working model (Fig. 6C), we discussed the relationship be-
tween Itch neddylation and JunB neddylation. Firstly, Itch-mediated
JunB neddylation occurred in the transcription domain of JunB directly
inhibited the transcription activity of JunB. Secondly, Itch actually cata-
lyzed JunB ubiquitination in T cell [34]. Finally, Itch neddylation could
enhance the activity of its ubiquitination ligase, and further accelerate
the degradation of substrate JunB. Thus, Itch regulated JunB'stranscription by the multiple means. However, The space and time of
these things occurred in physiological conditions needed to be further
explored in future.
Neddylation modiﬁcations have been shown to regulate transcrip-
tional factor stability and activity [35]. Itch-mediated neddylation
inhibited JunB transcriptional activity, consistent with that of E2F1
[36,37], ACID [38], BCA3 [39] and p73 [40]. Moreover, neddylation has
been also reported to promote transcriptional factor activity in the
case of Hif1-α [41], HuR [42] and BRAP2 [43]. Therefore, the effect of
neddylation on transcriptional factor activity seemed to function in a
substrate-speciﬁc manner. JunB was SUMOylated in T cells and
inhibited its transcriptional activity of speciﬁc targets IL-2 and IL-4
[44]. Therefore, ubiquitin-like modiﬁcation of JunB commonly
inhibited its transcriptional activity. Further investigations showed
the mechanisms was that Itch-mediated neddylation promoted the
ubiquitination-dependent degradation of JunB.
Notably, we found ﬁve members of Nedd4 family E3s could be
neddylated when co-expressed with Nedd8. The current ﬁndings sug-
gested that other HECT ligasesmight also function as Nedd8 ligases. Un-
like other members but like the yeast Rsp5, Itch could uniquely catalyze
self-mono neddylation. The neddylation site of Rsp5 was the single site
K45 [19], however, the case of Itch was not identical to Rsp5 and the
neddylation site of Itch remains unclear so far.
Although Itch could promote ubiquitination of JunB, thepre-require-
ment was its phosphorylation or the involvement of some scaffold pro-
teins. Tyrosine 371 phosphorylation by Src kinase Fyn was also crucial
for Itch-mediated JunB turnover. Tyrosine phosphorylation of Itch at
371 might modulate the afﬁnity between Itch and JunB. Moreover,
Nedd4 family interacting protein 2 (NDFIP2) binds to Itch and promotes
Itch auto-ubiquitination, subsequently enhances Itch-mediated
ubiquitination of JunB [26]. The serine and threonine phosphorylation
of Itch mediated by JNK1 cause a conformational change that disrupts
inhibitory intramolecular interaction between the WW and the HECT
Fig. 6.Neddylation of JunB inhibits its own transcriptional activity.(A) AP-1 luciferase activity assay was performed inHEK293T transformedwith the indicated plasmid combinations. (B)
Itch-mediated JunB neddylation inhibited AP-1 transcription activity. HEK293T was co-transformedwith the indicated plasmid combinations. (C, D) AP-1 reporter activity was promoted
by MLN4924 and NEDP1. After HEK293T cells were transfected as indicated for 36 h, 1 μMMLN4924 was added to the culture for 8 h, and then cells were collected and dual-luciferase
activity assay was conducted (C). AP-1 reporter activity assay was performed to assess the effect of NEDP1 on the transcription activity of JunB (D).(E) mRNA levels of the JunB well-
studied targets cyclinD1 were quantiﬁed by real-time PCR. HEK293T was incubated without or with 1 μM MLN4924. After 48 h, cells were collected for preparation of mRNA.(All
experiments were performed three times; bar graphs represent the mean plus standard deviation of these independent experiments. Values P b 0.05 were considered statistically
signiﬁcant. P b 0.05 was indicated with * and P b 0.01 was indicated with **. NS was abbreviated as “no signiﬁcant”).
1193H. Li et al. / Cellular Signalling 28 (2016) 1186–1195domain and augments the catalytic activity of Itch. Itch neddylation
maybe have a similar effects as its phosphorylation, where itch
neddylation could promote its ubiquitin activity of JunB by disrupting
its inhibitory intramolecular interaction.
JunBwas a positive regulator controlling primary osteoblast. JunBΔ/Δ
mice conditional deleted JunB in the embryo proper, were born viable,
but developed severe low turnover osteopenia caused by apparent
cell-autonomous osteoblast and osteoclast defects [45]. JunB has been
identiﬁed as a ubiquitination substrate of Smurf1 or WWP1 to inhibit
osteoblast differentiation in mouse MSCs [46,47]. Itch−/− BM-MSCgrew faster in an in vitro culture exhibited increased osteoblast differen-
tiation by compromising Itch-mediated JunB ubiquitination [28]. The
neddylation and ubiquitination system of JunB maybe cooperated
to regulate osteoblast differentiation. Whether Itch-mediated JunB
neddylation was involved in osteoblast differentiation needs to be fur-
ther investigated.
In conclusion, our study showed that JunB neddylation mediated
by HECT-type ligase Itch inhibited the transcriptional activity of
JunB. These ﬁndings deepen our understandings of HECT-type
Nedd8 ligase.
Fig. 7. Itch-mediated JunB neddylation promotes the degradation of JunB. (A) Flag-JunB, HA-Nedd8 and Itch WT or C830A were co-transfected into 293T cells. After 48 h transfection,
Samples were analyzed by western blotting. (B) The ubiquitination assay of JunB in 293T cells. Flag-JunB, HA-Ub, Myc-Nedd8 and Itch WT or C830A were co-transfected into 293T
cells. After 48 h transfection, co-immunoprecipitation assays were performed. (C) The working model, Itch-mediated JunB neddylation occurred in the transcription domain of JunB
directly inhibited the transcription activity of JunB. Moreover, Itch actually catalyzed JunB ubiquitination in T cell. Finally, Itch neddylation could enhance the activity of its
ubiquitination ligase, and accelerate the degradation of substrate JunB.
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